Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis

Indian Journal of Ophthalmology

Volumn 56, Issue 3, 2008, Pages 243-245

  Mehta, Hijab ^a   Mehta, Hitendra B ^a   Garg, Prashant ^b   Kodial, Harish ^c  

^a Infiniti Eye Hospital   (India)

^b L V PRASAD EYE INSTITUTE   (India)

^c Cumballa Hill Hospital   (India)

Author keywords

Aspergillus; Fungal keratitis; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CASE REPORT; CORNEA ULCER; FEMALE; FUNGAL EYE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; MIDDLE AGED; PYRIMIDINES; TRIAZOLES;

EID: 42549157971     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.40369     Document Type: Article

References (14)

1. Sharma S, Srinivasan M, George C. The current status of Fusarium species in mycotic keratitis in South India. J Med Microbiol 1993;11:140-7.
2. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004;15:321-7.
3. Garg P, Gopinathan U, Choudhary K, Rao GN. Keratomycosis: Clinical and microbiologic experience with dematiaceous fungi. Ophthalmology 2000;107:574-80.
4. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis: A three-year study. Indian J Ophthalmol 2003;51:315-21.
5. Gopinathan U, Garg P, Fernandes M, Sharma S, Atmanathan S, Rao GN. The epidemiologic features and laboratory results of fungal keratitis: A 10 year review at a referral eye care centre in South India. Cornea 2002;21:555-9.
6. Kim JE, Perkins SL, Harris GJ. Voriconazole treatment for fungal scleritis and epibulbar abcess resulting from scleral buckle infection. Arch Ophthalmol 2003;121:735-7.
7. Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002;34:563-71.
8. Reis A, Sundmacher R, Tintelnot K, Agostini H, Jensen HE, Althaus C. Successful treatment of ocular invasive mold infection (fusariosis) with the new antifungal agent voriconazole. Br J Ophthalmol 2000;84:932-3.
9. Hariprasad SM, Meiler WF, Holz ER, Gao H, Kim JE, Chi J, et al. Determination of vitreous, aqueous and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol 2004;122:42-7.
10. Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004;137:820-5.
11. Bunya VY, Hammersmith KM, Rapuano CJ, Brandon DA, Elisabeth JC. Topical and oral Voriconazole in the treatment of fungal keratitis. Am J Ophthalmol 2007;143:151-3.
12. Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrobial Agents Chemother 2007;51:239-44.
13. Sen P, Gopal L, Sen PR. Intravitreal Voriconazole for drug resistant fungal endophthalmitis: Case series. Retina 2006;26:935-9.
14. Laitha P, Shapiro BL, Srinivasan M, Prajna NV, Acharya NR, Fothergill AW, et al. Antimicrobial susceptibility of fusarium, aspergillus and other filamentary fungi isolated from keratitis. Arch Ophthalmol 2007;125:789-93.